Bruno Baillon

This inventor holds 4 USPTO granted patents and 1 published patent application and 2 EPO patents. Top assignees: Boehringer Ingelheim Animal Health USA Inc., Merial Limited, Sanofi. Active years: 2016-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Bruno Baillon. Retrieved from https://idiyas.com/inventor/bruno-baillon

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4 (Patent Applications = 1)

% Patents Active = 100.0

EPO Patents = 2 (Patent Applications = 4)

Average Co-Inventor Count = 5.9

ph-index = 2

Forward Citations = 8(Granted Patents)

Company Filing History:

2 out of 94

Boehringer Ingelheim Animal Health USA Inc.

Years Active: 2016-2021

Loading Chart...

4 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11130739 - Crystalline forms of ()-afoxolaner (2021-09-28),

2. 10662163 - Crystalline forms of (S)-afoxolaner (2020-05-26),

3. 10433552 - Process for the preparation of isoxazoline compounds (2019-10-08),

4. 9388143 - [object Object] (2016-07-12),

Title: Bruno Baillon: Innovator in Crystalline Forms

Introduction

Bruno Baillon is a notable inventor based in Le Poet, France, recognized for his contributions to the field of pharmaceutical innovations. With a total of four patents to his name, he has made significant strides in the development of crystalline forms of various compounds.

Latest Patents

Among his latest patents are the crystalline forms of ()-afoxolaner and (S)-afoxolaner. The present invention provides crystalline forms of the compound of formula (Ia) and processes for making these crystalline forms. Additionally, the patents include compositions comprising the crystalline forms and methods of use for these innovative compounds.

Career Highlights

Bruno Baillon has had a distinguished career, working with prominent companies in the pharmaceutical industry. He has been associated with Boehringer Ingelheim Animal Health USA Inc. and Merial Limited, where he contributed to advancements in animal health products.

Collaborations

Throughout his career, Baillon has collaborated with esteemed colleagues, including Stephane Kozlovic and Roelof Johannes Gorter De Vries. These collaborations have further enriched his work and contributed to the success of his inventions.

Conclusion

Bruno Baillon's innovative work in the field of crystalline forms has made a significant impact on pharmaceutical research and development. His patents reflect a commitment to advancing animal health through scientific innovation.

Profile summary based on public USPTO records.